Kim Golodetz | Senior Vice President, Principal, LHA Investor Relations |
David Arthur | Director and CEO |
Mark Rosenblum | Chief Financial Officer |
Dr. Daniela Santiesteban | Director, Protein Degradation, Development |
Ahu Demir | Ladenburg |
Welcome to the Salarius Pharmaceuticals Second Quarter 2022 Financial Results and Business Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Kim Golodetz with LHA Investor Relations.